<DOC>
	<DOCNO>NCT00003053</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Randomized phase III trial compare cisplatin etoposide chemotherapy treat patient stage I , stage II , stage IIIA non-small cell lung cancer surgically remove .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Stage I , II , IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed</brief_title>
	<detailed_description>OBJECTIVES : - Assess efficacy combination cisplatin etoposide radical surgery prolong relapse free overall survival stage I , II , IIIA non-small cell lung cancer . OUTLINE : This randomize study ( treatment v treatment ) . Patients stratify accord sex stage disease ( I vs II v IIIA ) . Patient receive cisplatin etoposide day 1-3 , every 28 day , 3 cycle . Patient may receive radiation therapy surgery discretion physician . PROJECTED ACCRUAL : Approximately 750 patient accrue 3 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven stage I , II , IIIA nonsmall cell lung cancer radical surgery No evidence lymphonodal enlargement postsurgical chest CT scan PATIENT CHARACTERISTICS : Age : 70 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : WBC least 3,500/mm3 Platelet count least 100,000/mm3 Hepatic : Not specify Renal : Creatinine great 1.5 time upper limit normal Pulmonary : FEV1 least 1 liter Other : Less 10 % weight loss past 3 month No prior malignancy except nonmelanoma skin cancer carcinoma situ cervix PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Radical surgery require</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
</DOC>